James Robinson Speciality Ingredients launches biotechnology R&D hub in Manchester

James Robinson Speciality Ingredients (JRSI) launched a new 2,000 sq ft biotechnology R&D facility in Hexagon Tower, Manchester, following a management buyout. The Biotome division will focus on sustainable ingredients for cosmetics and ophthalmic industries.

“James Robinson is one of the most trusted names in chemical development, and we’re thrilled to celebrate this heritage as we launch our Biotome division and get back to our roots in Manchester.”jrsi.com

• 1 source
• jrsi.comGlobal Speciality Manufacturer launches Manchester R&D Hub - James Robinson Speciality IngredientsJRSI TeamMay 25, 2022

Summarized from public sources; check the original articles before acting on it.